This position plays a critical role in the development and execution of BMS' WW & US medical strategy within our Thoracic/H&N portfolio. The Global Medical Oncology IO Thoracic/H&N Medical Product Lead (MPL) is a strategic leader with a broad scope of responsibilities across within the Worldwide Medical organization and a key leader of the cross-functional matrix providing medical insights and interpretation of evolving tumor landscapes and disseminating clinical data for the organization. The MPL has overall accountability to develop aligned medical strategies and execute core medical deliverables, including Integrated Evidence Plans, Scientific Narratives and External Engagement and Advocacy plans as a lead of the cross functional Asset/Indication Medical Strategy (AIMS) team. The Senior Director, MPL will have oversight over a team of colleagues covering multiple assets across a multitude of indications related to nivolumab/ipilimumab in thoracic and H&N cancers, nivolumab + relatlimab HD in thoracic and LCM indications and H&N disease area medical strategy. The MPL should be able to direct and navigate complex issues across the broad cross functional matrixed partners in their work to ensure optimal medical affairs strategy is developed and executed. This senior medical leader will report to the Global Medical Oncology Disease Area Head for Thoracic/H&N Cancers.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director
Industry
Chemical Manufacturing
Education Level
Ph.D. or professional degree
Number of Employees
5,001-10,000 employees